Core Points - VolitionRx Limited will host a conference call on November 14, 2025, at 8:30 a.m. U.S. Eastern Time to discuss its third-quarter financial and operating results and provide a business update [1][2] - The call will be hosted by key executives including the Group Chief Marketing & Communications Officer, the President and Group CEO, the Group CFO, and the Chief Scientific Officer [2] - A live audio webcast of the conference call will be available, and a telephone replay will be accessible until November 28, 2025 [3] Company Overview - Volition is a multi-national company focused on advancing the science of epigenetics, aiming to save lives and improve outcomes for individuals and animals with life-altering diseases through earlier detection and monitoring [4] - The company is developing and commercializing cost-effective blood tests for the detection and monitoring of various diseases, including certain cancers and conditions associated with NETosis, such as sepsis [5] - Volition's research and development activities are primarily based in Belgium, with additional facilities in the U.S. and London [6]